The global landscape of pediatric monoclonal antibody (mAb) clinical trials: an analysis of ClinicalTrials.gov

Agrata Sharma, Sanjana Mukherjee, Sharonann Lynch

Open source

DOI
10.3389/fped.2026.1846142
Published
2026-09-01
Container
Frontiers in Pediatrics
Publisher
Frontiers Media SA
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3389/fped.2026.1846142,
  title = {The global landscape of pediatric monoclonal antibody (mAb) clinical trials: an analysis of ClinicalTrials.gov},
  author = {Agrata Sharma and Sanjana Mukherjee and Sharonann Lynch},
  year = {2026},
  journal = {Frontiers in Pediatrics},
  doi = {10.3389/fped.2026.1846142},
  url = {https://doi.org/10.3389/fped.2026.1846142}
}

RIS

TY  - JOUR
TI  - The global landscape of pediatric monoclonal antibody (mAb) clinical trials: an analysis of ClinicalTrials.gov
AU  - Agrata Sharma
AU  - Sanjana Mukherjee
AU  - Sharonann Lynch
PY  - 2026
JO  - Frontiers in Pediatrics
DO  - 10.3389/fped.2026.1846142
UR  - https://doi.org/10.3389/fped.2026.1846142
ER  - 

APA

Sharma, A., Mukherjee, S., & Lynch, S. (2026). The global landscape of pediatric monoclonal antibody (mAb) clinical trials: an analysis of ClinicalTrials.gov. Frontiers in Pediatrics. https://doi.org/10.3389/fped.2026.1846142

Source records